In the hyperinsulinaemic contexts of obesity-driven insulin resistance, reduced beta-cell secretory function could be reasonably beneficial when paired with the reduced insulin demand of the KETO environment; however, reinstatement of a carbohydrate source would undoubtedly expose an insulin secretory defect. The gene discussed is INS; the disease is Obesity.